Showing results (201-210 of 326) with videos related to
Sort By:
Pageof 33
Journal of the National Cancer Institute|August 1, 1975
Inhibition of purified DNA polymerase of RNA tumor viruses by fluoranthene derivatives and analogues of tilorone hydrochlorideM Green, A Rankin, G F Gerard, et al.Anticancer Research|March 4, 2000
Synergistic effect of gemcitabine and irinotecan (CPT-11) on breast and small cell lung cancer cell linesH R Bahadori, C M Rocha Lima, M R Green, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 1, 1993
Multicenter phase II efficacy trial of toremifene in tamoxifen-refractory patients with advanced breast cancerC L Vogel, I Shemano, J Schoenfelder, et al.Chest|January 30, 1999
The 1997 International Staging System for non-small cell lung cancer: have all the issues been addressed?S S Leong, C M Rocha Lima, C A Sherman, et al.Proceedings of the National Academy of Sciences of the United States of America|September 15, 1992
Cloning and intracellular localization of the U2 small nuclear ribonucleoprotein auxiliary factor small subunitM Zhang, P D Zamore, M Carmo-Fonseca, et al.The Journal of Thoracic and Cardiovascular Surgery|March 1, 1995
Results of cancer and leukemia group B protocol 8935. A multiinstitutional phase II trimodality trial for stage IIIA (N2) non-small-cell lung cancer. Cancer and Leukemia Group B Thoracic Surgery GroupD J Sugarbaker, J Herndon, L J Kohman, et al.Journal of Radiological Protection : Official Journal of the Society for Radiological Protection|December 13, 2005
The development of the UK radon programmeG M Kendall, B M R Green, J C H Miles, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 1, 1984
Combination intraperitoneal chemotherapy with cisplatin, cytarabine, and doxorubicin for refractory ovarian carcinoma and other malignancies principally confined to the peritoneal cavityM Markman, S B Howell, W E Lucas, et al.Science (New York, N.Y.)|October 22, 1993
The conserved pre-mRNA splicing factor U2AF from Drosophila: requirement for viabilityR Kanaar, S E Roche, E L Beall, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 24, 1999
Radiosensitization with carboplatin for patients with unresectable stage III non-small-cell lung cancer: a phase III trial of the Cancer and Leukemia Group B and the Eastern Cooperative Oncology GroupG Clamon, J Herndon, R Cooper, et al.Pageof 33